Replies to post #97261 on Regen BioPharma Inc (RGBP)

[LoveAndLight]

Wow! Dr. Shahin Rafii from Cornell University is an amazing man. His world of expertise coming into Regen BioPharma's new acquisition plans is off the charts incredibly amazing! Everyone who is invested in Regen BioPharma should watch this video podcast interview with him! :-)

Natureboy1 posted:
9. Intellectual Property

It is understood that the IP that will be licensed into Canary will originate from Cornell University and specifically from the laboratory of Dr. Shahin Rafii. The final IP will be included in the definitive agreement as an appendix. This IP allows for the creation of patient-derived tumor on vascular nets for in vitro testing of therapeutic agents.

Start at 18:10 to see our guy, Dr. Shahin Rafii.

Blessings and best wishes,
LoveAndLight :-)